Menu
Back to Journals » Drug Design, Development and Therapy » Volume 9
Review
Brentuximab vedotin for relapsed or refractory Hodgkin’s lymphoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 13,106 | Dovepress* | 10,449+ | 1,890 | 12,339 | |
| PubMed Central* | 2,657 | 729 | 3,386 | ||
| Totals | 13,106 | 2,619 | 15,725 | ||
|
*Since 23 March 2015 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar